Related Experiment Video
Updated: May 14, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Progressive multifocal leukoencephalopathy (review)].
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|February 5, 2013
Summary
Progressive multifocal leukoencephalopathy (PME) is a fatal CNS demyelinating disease often occurring during immunosuppression. This study reviews PME
Area of Science:
- Neuroimmunology
- Neurology
- Infectious Diseases
Background:
- Progressive multifocal leukoencephalopathy (PME) is a severe demyelinating disease of the central nervous system (CNS).
- PME is an opportunistic infection linked to immunosuppression from chronic illnesses or treatments.
- The condition is frequently fatal, highlighting the need for better understanding and management.
Purpose of the Study:
- To explore the underlying mechanisms of PME development.
- To discuss current diagnostic strategies for PME.
- To review existing and potential therapeutic interventions for PME.
Main Methods:
- Literature review of PME pathogenesis.
- Analysis of diagnostic criteria and imaging findings for PME.
- Examination of treatment options for PME, including antiviral and immunomodulatory therapies.
Main Results:
- PME pathogenesis involves reactivation of the JC virus in oligodendrocytes.
- Diagnosis relies on clinical presentation, MRI findings, and cerebrospinal fluid analysis.
- Treatment options are limited, with focus on managing immunosuppression and supportive care.
Conclusions:
- PME remains a significant challenge in immunocompromised individuals.
- Further research into PME mechanisms and novel therapies is crucial.
- Improved diagnostic and treatment protocols are needed to improve patient outcomes.
More Related Videos
26:48Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...